Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04258891 · ClinicalTrials.gov registry record

Multidimensional System to Dynamically Predict Graft Survival After Kidney Transplantation

A clinical trial of Kidney Transplant Failure, sponsored by Paris Translational Research Center for Organ Transplantation.

Completed
Registry status
14,000
Enrollment target
18
Study locations

NCT04258891 is a study of Kidney Transplant Failure that has completed, run by Paris Translational Research Center for Organ Transplantation. The registered enrollment target is 14,000 participants. The trial reports 18 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04258891, a study of Kidney Transplant Failure, has completed, sponsored by Paris Translational Research Center for Organ Transplantation.

COMPLETED
Registry status
14,000 participants
Enrollment target
18
Study locations

Study Summary

The incidence of end stage renal disease (ESRD) is rapidly increasing, now affecting an estimated 7.4 million people worldwide. Numerous parameters such as demographic, clinical and functional factors drive the deterioration of the kidney, ultimately leading to ESRD. Although some ESRD prediction models have been derived in the past years, none of these models are dynamic: they do not integrate the repeated measurements recorded throughout individuals' follow-up. As highlighted in several studies, kidney function repeated measurements (i.e., trajectories) are highly associated with graft survival after kidney transplantation. The investigators made the hypothesis that these trajectories may bring relevant information in the context of graft survival risk prediction model. Hence, combining these trajectories with standard graft survival risk factors may enhance prediction performance. This could permit to derive a robust tool that could be updated over time by continuously capturing patient' personal evolution.

Conditions Studied

Interventions

  • OTHER No intervention

Study Locations (18)

Other

  • Unidad de Trasplante Renopáncreas, Centro de Educación Médica e Investigaciones Clínicas - Buenos Aires
  • Universidade Federal de São Paulo, Hospital do Rim, Escola Paulista de Medicina - São Paulo
  • Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Renal Transplantation Service - São Paulo
  • Clinica Alemana de Santiago - Santiago
  • Department of Nephrology, Arterial Hypertension, Dialysis and Transplantation, University Hospital Centre Zagreb, School od Medicine University of Zagreb - Zagreb
  • Department of Nephrology, Centre Hospitalier Universitaire de Montpellier - Montpellier
  • Nephrology Dialysis Transplantation Department, University of Lorraine, Centre Hospitalier Universitaire de Nancy - Nancy
  • Kidney Transplant Department, Saint-Louis Hospital, Assistance Publique - Hôpitaux de Paris - Paris
  • Kidney Transplant Department, Necker Hospital, Assistance Publique - Hôpitaux de Paris - Paris
  • Department of Transplantation, Nephrology and Clinical Immunology, Hôpital Foch - Suresnes
  • Department of Nephrology and Organ Transplantation, Centre Hospitalier Universitaire Rangueil - Toulouse
  • Bretonneau Hospital, Nephrology and Immunology Department - Tours
  • Department of Nephrology, Hospital del Mar - Barcelona

California

  • Department of Medicine, Division of Nephrology, Comprehensive Transplant Center, Cedars Sinai Medical Center - Los Angeles

Illinois

  • Division of Transplantation, Department of Surgery, Feinberg School of Medicine, Northwestern University - Chicago

Maryland

  • Department of Surgery, Johns Hopkins University School of Medicine - Baltimore

Minnesota

  • William J. von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic - Rochester

New York

  • Albert Einstein College of Medicine, Renal Division Montefiore Medical Center, Kidney Transplantation Program - New York

Trial Details

FieldValue
Enrollment Target 14,000 participants
Start Date 2004-01-01
Est. Completion 2020-06-30

What the Registry Record Tells You About NCT04258891

The ClinicalTrials.gov registry entry for NCT04258891 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 14,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Paris Translational Research Center for Organ Transplantation, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Kidney Transplant Failure appearing as the primary indexed condition, and to 1 intervention - of which No intervention is the first listed.

NCT04258891 reports 18 study locations spanning 6 distinct geographic areas - top geographies include Other, California, Illinois.

Frequently Asked Questions

What is clinical trial NCT04258891 about?

NCT04258891 is a clinical study titled "Multidimensional System to Dynamically Predict Graft Survival After Kidney Transplantation". The incidence of end stage renal disease (ESRD) is rapidly increasing, now affecting an estimated 7.4 million people worldwide. Numerous parameters such as demographic, clinical and functional factors drive the deterioration of the kidney, ultimately leading to ESRD. Although some ESRD prediction mo...

What is the current status of trial NCT04258891?

This trial is currently completed. The enrollment target is 14,000 participants. The study started on 2004-01-01. Estimated completion is 2020-06-30.

What conditions does trial NCT04258891 study?

This clinical trial studies the following conditions: Kidney Transplant Failure.

What interventions are being tested in trial NCT04258891?

The interventions under investigation include: No intervention (OTHER).

Who is sponsoring clinical trial NCT04258891?

This trial is sponsored by Paris Translational Research Center for Organ Transplantation, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04258891 being conducted?

This trial has 18 study locations across California, Illinois, Maryland, Minnesota, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Kidney Transplant Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.